Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04764773
Status:
COMPLETED
Last Update Posted:
2021-11-02
First Post:
2021-02-19
Brief Title:
Persistence of Symptoms After Improvement of Acute COVID-19
Sponsor:
Sohag University
Organization:
Sohag University
Study Overview
Official Title:
Persistence of Symptoms After Improvement of Acute COVID19 Infection in Sohag Governorate Egypt A Longitudinal Study
Status:
COMPLETED
Status Verified Date:
2021-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COVID-19
Brief Summary:
Coronavirus disease pandemic has been started in late 2019 Survivors of COVID-19 are significantly more likely to develop clinical sequelae three months after discharge from the hospital than those without COVID-19 infection This is true not only for general and respiratory symptoms but also for cardiovascular and psychosocial symptoms This suggests that these symptoms may indeed be the sequelae of recovery for COVID-19 survivors So we aimed to detect the prevalence and to evaluate the type of symptoms that could persist after the recovery from COVID19 infection in Sohag governorate Egypt
Detailed Description:
About one hundred patients who were test positive for SARS-CoV2 and were improved and discharged from Sohag isolation hospitals and isolation department for COVID19 in Sohag University hospitals during the period from 15th May 2020 to 25th July 2020 will be included in our study Patient improvement and discharge criteria include 10 day from symptoms onset in addition to 3 day free of fever and respiratory symptoms
Patients with severe complex illness pregnant or lactating females and patient who refuse to participate or give complete detailed history will be excluded from the study
The study protocol will be approved by the scientific Research Ethical committee Faculty of Medicine Sohag University A control group of healthy volunteer who were age and sex matched to our patient were included
After taken informed consent according to Sohag University Ethical Committee the baseline data will be collected from Sohag isolation hospital of COVID19 then the researchers will perform interviews with all participants through mobile phone The interview will include
Name Optional
Age
Sex
Occupation
Presence of DM HTN or any chronic illness
Asking about Smoking
The date of catching COVID19 infection
Asking about symptoms of COVID19 infection and duration of each symptom
Asking about any residual symptoms as Fatigue Myalgia Arthralgia Chest pain Dyspnea Dry cough Productive cough Sore Throat Anosmia Loss of taste sensation Nausea Anorexia Diarrhea Redness of the eye Headache Confusion and Depression
Statistical analysis
Data will be analyzed using STATA version 142 Statistical Software Release 142 College Station TX Stata Corp LP Quantitative data will be represented as mean standard deviation median and range normally distributed Qualitative data will be presented as numbers and percentages Chi square test will be used for comparison of percentages in different groups P value will be considered significant if it was less than 005
Patients with severe complex illness pregnant or lactating females and patient who refuse to participate or give complete detailed history will be excluded from the study
The study protocol will be approved by the scientific Research Ethical committee Faculty of Medicine Sohag University A control group of healthy volunteer who were age and sex matched to our patient were included
After taken informed consent according to Sohag University Ethical Committee the baseline data will be collected from Sohag isolation hospital of COVID19 then the researchers will perform interviews with all participants through mobile phone The interview will include
Name Optional
Age
Sex
Occupation
Presence of DM HTN or any chronic illness
Asking about Smoking
The date of catching COVID19 infection
Asking about symptoms of COVID19 infection and duration of each symptom
Asking about any residual symptoms as Fatigue Myalgia Arthralgia Chest pain Dyspnea Dry cough Productive cough Sore Throat Anosmia Loss of taste sensation Nausea Anorexia Diarrhea Redness of the eye Headache Confusion and Depression
Statistical analysis
Data will be analyzed using STATA version 142 Statistical Software Release 142 College Station TX Stata Corp LP Quantitative data will be represented as mean standard deviation median and range normally distributed Qualitative data will be presented as numbers and percentages Chi square test will be used for comparison of percentages in different groups P value will be considered significant if it was less than 005
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None